Skip to content

PRODUCTS
CONTACT
COMPANY
EVENTS
ACADEMY
NEWS
Generic selectors

Exact matches only

Search in title

Search in content

Post Type Selectors

Search in pages

Search in products

Generic selectors

Exact matches only

Search in title

Search in content

Post Type Selectors

Search in pages

Search in products

Characterization/Classification

Home/Next Generation Flow Solutions/Clinical Oncohematology/Characterization/Classification

Characterization/Classificationcyt-jaramos2019-09-19T11:38:35+01:00

Characterization/Classification in Oncohematology

Acute Leukemia

BCP-ALL, AML/MDS and T-ALL panels for the diagnosis of Acute Leukemia

Next Generation Flow™ Solution for Acute Leukemia

Learn more about the complete solution for acute leukemia characterization…

Chronic Lymphoproliferative Disorders

B-CLPD, T-CLPD and NK-CLPD panels for the diagnosis of Chronic Lymphoproliferative Disorders

Next Generation Flow™ Solution for Chronic Lymphoproliferative Disorders

Learn more about the complete solution for chronic lymphoproliferative disorders characterization…

Plasma Cell Dyscrasias

PCD panel for the diagnosis of Plasma Cell Dyscrasias

Next Generation Flow™ Solution for Plasma Cell Dyscrasias

Learn more about the complete solution for plasma cell dyscrasias characterization…

Our products

Next Generation Flow Solutions
Acute Leukemia
Chronic Lymphoproliferative Disorders
Plasma Cell Dyscrasias
Primary Immunodeficiencies
Infinicyt™

Summary on the use of your data

Cytognos recognizes the importance of protecting your personal information and is committed to processing it responsibly and in compliance with applicable data protection laws.

Responsable: Cytognos, S.L.
Purpose: manage and answer your enquiries, send you direct marketing related to Cytognos products and services..
Legitimation: you give your consent by selecting the Privacy Policy's checkbox.
Period of maintenance of your data: while you interact with us and until you unsubscribe from our informative communications and direct marketing.
Recipients: we may share your personal data with our professional advisors. We can also share your data with government authorities if required by law or in case it is necessary for the protection of our legitimate interest in compliance with applicable laws.
Rights: you have the right of access, rectification, deletion, portability of your data, as well as the right to limitation, opposition to treat or withdrawal of consent for processing your personal data.

Please go to Privacy Policy.

The company

About us
Contact & Support
Events
Work with us
Projects
Subscribe to Newsletter

Useful information

EuroFlow™
Cytognos technology
Minimal Residual Disease
Clinical trials
Scheduled webinars
FAQs

Legal Notice

Legal Notice
Terms of use
Privacy Notice
Cookie Policy
Terms and Conditions of Sale
Anti-corruption Policy

Cytognos, S.L. Quality Management System complies with ISO 13485:2016 for the design, development, manufacture and sale of flow cytometry reagents, antibodies, kits and software for In Vitro Diagnostic and ISO 9001:2015 for the design, development, manufacture and sale of flow cytometry reagents, antibodies, kits and software for In Vitro Diagnostic and research.
Cytognos, S.L. products for In Vitro Diagnostic are bearing a CE mark.

Copyright © 2023 Cytognos, S.L.. All Rights Reserved.

Cytognos™, Infinicyt™, APC-750™, OC515™, Bulklysis™ and Next Generation Flow™ are trademarks or registered trademarks of Cytognos, S.L.
EuroFlow™ is a trademark or registered trademark of The European Scientific foundation for Laboratory Hemato Oncology (ESLHO).
BD FACSCanto™ II and BD FACSLyric™ are trademarks or registered trademarks of Becton, Dickinson and Company or its affiliates.

All products listed are labeled with some regulatory status as per indicated below:
“RUO” or “For Research Use Only”: for Research Use Only. Not for use in diagnostic or therapeutic procedures.
“CE-IVD”: in vitro diagnostic medical device bearing a CE mark.
“LUO” or “Laboratory Use Only”: general purpose laboratory reagents.
“ASR” or “Analyte Specific Reagent”: reagents in which the analytical and performance characteristics are not established. ASRs are regulated by the US Food and Drug Administration (FDA).